Explore / Peer-reviewed article
Peer-reviewed article

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Yaden DBiD, Graziosi M, Owen AMiD, Agin-Liebes G, Aaronson STiD, Allen KE, Barrett FSiD, Bogenschutz MP, Carhart-Harris RiD, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths RiD, Grob CS, Gründer GiD, Gukasyan N, Heinzerling KGiD, Hendricks PSiD, Holze F, Horton DM, Johnson MWiD, Kelmendi B, Knatz Peck S, Koslowski MiD, Liechti MEiD, Mertens LJ, Moreno FA, Nayak SM, Nicholas CRiD, Preller KH, Rieser NMiD, Ross S, Sergi K, Sloshower J, Smigielski LiD, Stenbæk DSiD, Vollenweider FX, Weiss B, Wolff MiD, Yaden ME

Psychedelic medicine (New Rochelle, N.Y.)Feb 27, 2025United States, Germany, Switzerland, France, Denmark7 citationsDOI: 10.1089/psymed.2024.0019

Abstract

<h4>Introduction</h4>Serotonergic psychedelics, serotonin 2A receptor agonists such as psilocybin that can result in substantially altered states of consciousness, are used in recreational and research settings. The safety of psychedelic experiences in research settings is supported by controlled physical environments, presence of clinical and medical staff to address emergent issues, screening for personal and family history of potential contraindications, and psychoeducational preparation with psychological support. Research settings typically provide psychoeducation to participants verbally and in writing (e.g., informed consent), and such documents and conversations can provide safety-related information-but may also introduce a wide range of expectancies. Such expectancies might involve the specific character of the acute subjective effects of psychedelics, possible side effects, and anticipated outcomes.<h4>Methods</h4>To better understand the content of this psychoeducation, we gathered study materials from many psilocybin studies conducted in the past two decades in healthy and therapeutic populations. We conducted a reflexive thematic analysis to better understand these documents.<h4>Results</h4>While these documents varied substantially between studies, we identified themes intended to lower levels of risk and optimize therapeutic effects from psychedelic treatments. The most frequently coded themes related to (1) biological and physical safety, (2) psychological safety and well-being, (3) aspects of setting, and (4) potential for expectancies. Prioritizing biological and psychological safety was evident in the materials from all sites. Furthermore, we identify potential contributors to expectancy unrelated to safety and suggest that these extrapharmacological elements be studied systematically in future research.<h4>Conclusions</h4>Ideally, future research should strive to maximize safety while attempting to minimize extraneous expectancies.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

SafetyPsychoeducationExpectanciesPsychedelic-assisted PsychotherapyReflexive Thematic Analysis

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.